Steven Cook Sells 33,000 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 33,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $19.89, for a total value of $656,370.00. Following the sale, the chief financial officer directly owned 133,359 shares in the company, valued at approximately $2,652,510.51. This represents a 19.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Omada Health Stock Up 3.1%

Shares of Omada Health stock opened at $22.62 on Thursday. The company has a market capitalization of $1.34 billion and a price-to-earnings ratio of -83.78. The stock’s 50-day simple moving average is $17.00 and its 200-day simple moving average is $14.98. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. On average, equities analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Barclays boosted their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Canaccord Genuity Group set a $24.00 price target on shares of Omada Health in a research note on Friday, May 8th. Weiss Ratings upgraded Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 26th. Finally, BMO Capital Markets reduced their target price on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, March 6th. Ten investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $22.91.

Institutional Investors Weigh In On Omada Health

A number of hedge funds have recently bought and sold shares of OMDA. Geode Capital Management LLC bought a new stake in shares of Omada Health in the 2nd quarter worth about $637,000. Walleye Capital LLC bought a new stake in Omada Health during the second quarter worth approximately $458,000. Ilex Capital Partners UK LLP bought a new stake in Omada Health during the second quarter worth approximately $201,000. Soros Fund Management LLC purchased a new stake in Omada Health during the second quarter valued at approximately $640,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Omada Health in the 2nd quarter valued at approximately $32,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.